chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started sweating real bad; It was just unusual the amount that I sweat; This is a spontaneous report from a contactable consumer.A 78-years-old male patient received First dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Lot Number: EL9265) via an unspecified route of administration on 12Feb2021 at a single dose for covid-19 immunization.Patient relevant medical history of ulcer from 1968, arthritis pain (about 3 months prior to receiving my vaccine, Patient was having Arthritis pain in right shoulder and a week after receiving vaccine which was 19Feb2021, he put a Heating pad on right shoulder for the Arthritis pain and that night when he went to bed he started sweating real bad, everything was wet his sheet, pillow case from sweating), neoplasm malignant from 2004, Ulcer. Concomitant medications included lisinopril (LISINOPRIL), acetylsalicylic acid (ASPIRIN) and ergocalciferol (VIT D).The patient received second dose on 05Mar2021. The patient underwent blood test and result was unknown.On 19Feb2021, patient started sweating real bad, It was just unusual the amount that he sweat and had not received any treatment. Patient did not received any treatment. The outcome of the event was unknown.
1 day after general body fatigue and weakness, headache, neck pain and soreness at injection site. Lasted 24 hours.  8 days after and currently,  2 inch long by 1 inch wide red, warm raised painful area at injection site
Patient diagnoses 11/30/21. Adm 12/14/21 to Hospital. Condition declined two days after admission. Started on Levophed, placed on vent. Patient expired (was DNR).
Patient describes initial symptoms around 8 pm, headache, feeling feverish, local pain, erythema and edema on site of Menactra injection.  Same night she developed hives and felt very hot.  She reports that she took Acetaminophen some time after feeling hot and to help with headache. She did not visit any facility to get treatment and neither called my Office, she reports that fever subsided by next day, the swelling was present for about 2 days and the hives were improving and recurring for about 2 weeks.  Symptoms have subsided and did not recur after 2 weeks of  injection. She came today for second Bexsero  appt but declined vaccine and described symptoms.
Headache, fatigue, dizzy Narrative: Mild headache 4/15, mild nausea 4/15 and moderate dizziness 4/15. Resulted in unable to work 4/15/2021.
Intentional Off Label Prescription by HCP: Imovax prescribed with off label diagnosis W55.81XA Bitten by other mammals with no adverse event; Initial information received on 07-Sep-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 24-year-old and unknown gender patient who experienced intentional off label prescription by hcp: IPV (VERO) [Imovax] prescribed with off label diagnosis, bitten by other mammals with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date the intentional off label prescription by hcp:  IPV (VERO) [Imovax] suspension for injection at dose 1ml via subcutaneous route was prescribed with off label diagnosis: bitten by other mammals (Animal bite) with no adverse event (off label use) (unknown latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown.
Patient started to feel light headed and hot 3-5min after vaccination. She was in transition from consult room to waiting room for 15m waiting period. Patient was observed starting to look pale so was asked to be seated. Upon sitting she stated she was very anxious from the vaccine and starting to feel 'sick'. Patient was upset and crying also stated her hearing seemed muted-she continued to say she was over heated and was visibly sweating. I attempted to get cool cloths for her-while mom stood in front of her chair in case she lost consciousness.  Within the next 5min period patient vomited 1-2 x and had increased pulse rate. She was given cool cloths and ice pack and water over the next 15minutes. Her pulse began to normalize and she stopped crying and sweating.  Her color returned to normal and she stated she was feeling better after getting sick and did not feel light headed any longer.  We had her wait for another 15minutes until she stated she was feeling more normal, she had no signs of reaction on her arm or other symptoms. She did state that she had not ate or drank anything prior to the vaccine and had a big fear of needles. Patient went home with both parents, will follow up later today to ensure no issues.
Seen 3/7/2003 in office for ? "twitching" episode lasting 20 seconds with completely normal exam. Seen later Hospital for seizure. Child hospitalized through 3/13/2003. Child saw neurologist and had CT scan, diagnosed with Lissencephaly (severe cortical dysplasia bilaterally). Also had abnormal EEG consistant with diffuse cerebral dysfunction with left temporal potentially epileptogenic area.
Daughter suddenly stopped breathing, turned blue,  eyes open & fully dilated,  and making a terrible sound. Called 911, rushed to ER by ambulance, ER mis-diagnosed her with laryngospasms, sent us to Pediatrician for follow up. Pediatrician concurred with ER, sent us to ENT specialist for follow up. ENT specialist did scope of larynx--said everything looked fine. Went back to pediatrician, asked about the possibility of febrile seizures after second episode occurred. She agreed that it could be, sent a referral to Neurologist for follow up. After waiting weeks to get scheduled with a neurologist and several more months to get in we held off.  Shortly after, another episode occurred at the Dr's office , right on the doctor's table while we were there for ear infection treatment. The doctor we saw that day finally diagnosed her with febrile seizures after witnessing the  seizures first hand. Eventually found a different practice where the new Doctor diagnosed Encephalitis, and liver damage due to metal toxicity in liver from the 12 month vaccine series.
pt recvd vax & had grunting & gasping for air; noticed lips, face, hands & feet were blue & was shaking all over, like tremors; just staring-cried out mama once then was unresponsive; limp, eyes rolling around, t104;
Our Health Dept secretary expressed she bumped into the pt's mom over the weekend and the mom proceeded to tell our secretary that her child had a reaction from the Pfizer vaccine that was taken 4 days ago.  It was reported to me Monday am, 9/20/2021.  I reached out to the mom but got no response, I left a message on her cell's voice mail to call me back.  Mom called back on 9/21/21 @ 9:08 am.  I asked the mom to explain to me what happened to her daughter and stated " my daughter lips swelled up and her eyes were puffy". When asked at what time this occurred, mom replied "she woke up the next morning like that, I gave her some Benadryl and Tylenol and she lay back down, when she got up later in the day, she was alright".  I asked the mom did the pt experience any trouble breathing, mom replied, "oh yeah, she did a little bit, her asthma was trying to act up, so I gave her her Albuterol Inh and like I said, when she woke up later in the afternoon , she was fine".  I asked mom did she take the pt to the ER, mom stated "no I didn't".  I advised the mom on pt had having what seemed to be and Anaphylaxis reaction to the Pfizer vaccine and she is not to receive it ever again unless under the care of her PCP.  I advised mom that we wouldn't be able to complete that series of Pfizer d/t her reaction.  I advised mom to seek any medical attention from ER or the Pediatrician's office of any other problems were to occur.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 57 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or around 22-MAY-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions.   On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Information has been received from a physician concerning an 18 year old female who was vaccinated with a dose of Gardasil.  The patient became pale and lightheaded.  Subsequently, the patient recovered from pale and lightheaded.  Additional information has been requested.
Dizziness, body pain and soreness, swelling and redness and heat in the area immunized, fatigue, one episode of night sweat
I experienced the inability to move my arm for two days along with chills after receiving the vaccine. Then, about 6 weeks later, I experienced shortness of breath and ended up going to the ER. The doctor mentioned in-stage  Emphysema from the CT Scan results. I left the ER after receiving Albuterol and a breathing treatment. I went to my doctor for follow up and was told that I had mild to moderate Emphysema after performing another CT Scan and Pulmonary Function test and I went back the following month for a follow up visit. I experienced numbness in my arms and hands (starting to turn purple). I am scheduled to have an Echocardiogram and Stress Test in November. The tingling and numbness in my arms are beginning to get better.
This is a spontaneous report from a contactable nurse reporting on behalf of a physician. This nurse reported similar events for 3 patients. This is the 1st of 3 reports. A patient of unspecified age ethnicity and gender received PREVNAR 13, via an unspecified route of administration in the arm, on an unspecified date, at single dose, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced severe arm pain following the injection on an unspecified date with outcome of unknown. Sender's Comments: Linked Report(s): US-PFIZER INC-2016503345 Same reporter/drug/event, different patient; US-PFIZER INC-2016503348 Same reporter/drug/event, different patient.
At 2 mo. old infant received DTP, 6 hrs later developed blueness & pallor of face, generalized weakness, lasting 30 min. to 1 hr, @ 4 mo. old received DT/OPV, 8 hrs later, again dev. blueness & pallor of face & gen'l weakness for 20-30 min.
Dry cough then wet cough. Some headache, no fever. I tested positive for 4-5 with COVID-19. I no longer test positive but still have a lingering cough. I contacted my Dr. and they gave me PAXLOVID for 5 days.
burning in upper arm;very painful weakness in arm;unable to pull up under garments, bed covers or turn the steering wheel w/o a lot of discomfort;
Patient completed HPV series at 13 (3 doses) but received 4th dose 1/18/2023.
Dizziness, Myalgia, Arthralgia, Fever, fatigue Narrative:
Fever, chills. Arm very sore at injection site. Severe hradache, body aches and pains, fatigue, dizziness
This spontaneous report was received from a nurse referring to a male patient (the patient's age was reported as 40 without units). The patient's concurrent conditions included hypertension. The patient had no drug reactions/allergies. On 19-OCT-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 intramuscularly in the deltoid area, lot # N022703, for prophylaxis (expiration date was not reported). On the same date, the patient was vaccinated with FLUZONE on the same arm (dose, lot # and expiration date were not reported). Concomitant therapies included FLONASE, acetaminophen, NORCO, loratadine (manufacturer unknown) and naproxen. On 20-OCT-2017, the patient experienced "cellulitis like symptom" from the area below the injection site down to the elbow. It was sated that the patient sought her physician and an unspecified treatment was given for the adverse event. No laboratory diagnostic tests were performed. At the time of reporting, the outcome of the event was unknown. The causality assessment between cellulitis with PNEUMOVAX 23 was not provided. Upon internal review cellulitis was determined to be a medically significant event.
Headache, Sedation, Myalgia, Arthralgia, Diarrhea,  NauseaVomiting, Swollen lymph nodes, Chills, Pain/Swelling/Itching @ injection site Narrative:
Immediately after injection, patient felt tingling all the way down her arm after her vaccine was administered. She alerted a pharmacist about 15 minutes after her dose that her right hand felt numb. She waited an additional 15 minutes and said her hand felt better and she was comfortable leaving the vaccination site.
Pt experienced itching on both hands and on face but it comes and goes, also pt stated his face felt warm but color was normal.  Pt states he was allergic to Benadryl.
Dose #1: Headache lasting longer than 2 weeks, possible Cellulitis at injection site that covered about half of my right arm, that started that evening as a red raised spot, swollen, very painful, hot to the touch and continued to grow for the next 48 hrs after injection. It took about a week and a half for this to resolve.   Dose #2: Severe headache 24 hrs after injection. Raised red, swollen, hot to touch and painful bump that seems to be starting out as possible cellulitis again. It has continued to get bigger since the initial injection.
Headache; Fatigue; Brain fog; Chills; Hot flashes; Nausea; Low Energy; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included stroke, on Nov2020 and seasonal allergy. The patient had known allergies to medications, food, or other products. The patient received medication (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 18:30, the patient experienced headache, fatigue, brain fog, chills, hot flashes, nausea, low energy and dizziness. Therapeutic measures were not taken for the adverse events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, fatigue, brain fog, chills, hot flashes, nausea, low energy and dizziness was resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
After the original pain on my left shoulder, I have excruciating pain when ever I do most things. It hurts from the elbow up my arm all the way to the left side of my back.   Muscle pain, like I am being stab by a sharp knife when ever I make movements with my left arm.
Pt developed left sided Bell's palsy within 24 hours of injections. No treatment required.
she's developed shingles; A spontaneous report was received from a consumer concerning a 75-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events developed shingles/Herpes zoster.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unavailable) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) developed shingles.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), developed shingles was not resolved at the time of reporting.
patient in for second covid vaccine  with in 5-10 minutes after administration patient c/o feeling chilled in her toes and moving up her knees temp 98.8 temporal artery patient asked for a drink of water upon returning w request patient stated sx of coldness and now tingling had moved all the way up her chest and she was also experiencing a sensation of warmness denied chest pain denied trouble breathing reported a sudden onset of headache back of head 5/10 says she does normally have headaches but did not come in with one moved patient to exam room so she could lie down dr notified patient bp initally 130-140/103 pulse 80s o2 on room air 98 EKG completed and was normal SR  reviewed by dr patient c/o some off and on chest pain upper L chest BP recheck 160s/106 pulse still 80s 2l o2 applied via nasal cannula 99% patient shaky benadryl 25mg admin per verbal order from dr epi pen on stand by patient c/o sleepy patient alert and oriented throughout 911 dispatched for patient to be taken to ED for observation patient denied trouble breathing throughout she did report she had taken her daily allergy medication zyrtec today when questioned by dr patient did report a typical immune like response to the first dose of the vaccine which included fatigue body aches and nausea but didn't occur until around 5 hours after administration of the vaccine at time of EMS arrival patient still c/o headache c/o fatigue/sleepiness trouble keeping her eyes open appeared shaky BP taken by EMS was 180s/106 Patient transported to Emergency Department, by EMS.
Needle separated from syringe during vaccination. It is unknown how much vaccine was lost and how much was successfully administered.; This is a spontaneous report from a contactable other health care professional. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE BIONTECH, Lot number: ER8730) intramuscularly in the left arm on 20Mar2021 at 12:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, unknown if patient was diagnosed with COVID-19. Since the vaccination, unknown if patient had been tested for COVID-19. On 20Mar2021, the patient experienced needle separated from syringe during vaccination and it was unknown how much vaccine was lost and how much was successfully administered. Event didn't result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken for the event. The outcome of the event needle separated from syringe during vaccination and is unknown at the time of report.   No follow-up attempts are needed. No further information is expected.
Patient reported itching on arms within 45 minutes of vaccination.  Given Benedryl; symptoms resolved and patient was released to home.
Seen Health Center on 2-25-2014 with fine rash face - upper chest and back. Given a MEDROL dose pak 24mg (taper) 2 weeks prior to 2-25-2014 - by Dr. - rash came on within 1-2 wks after Zoster vaccine. Still has rash and itching 3-10-14. Patient started on VALTREX 500mg 1 PO TID 3-10-2014 x 30days. Improving.
24 hours after started with nausea, anorexia, diarrhea.  Urging when nothing there.  it went away after two weeks.  after 2nd dose it came back and while it has gotten better, it remains with some nauseas (constant), anorexia, urges all the time.
pt recv vax;had T of 102.8 rectally w/ apap;started diarrhea w/ projectile vomiting;dx as post immunization viral synd;also seen by MD;
sick to his stomach; Weak; Nauseated and sick to his stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to his stomach), ASTHENIA (Weak) and NAUSEA (Nauseated and sick to his stomach) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to his stomach), ASTHENIA (Weak) and NAUSEA (Nauseated and sick to his stomach). At the time of the report, ABDOMINAL DISCOMFORT (sick to his stomach), ASTHENIA (Weak) and NAUSEA (Nauseated and sick to his stomach) had not resolved.            No concomitant medications were reported. No treatment information was provided by the reporter.
Soreness in right arm, headache, pain in neck. By 5:00 PM, arm was very swollen and hot above elbow, pain in neck and headache continued.  Visited Dr. on 10/03/2012, advised it was obviously a reaction to something, but did not appear to be an allergic reaction.  He advised to put cold compress on it, and return if condition persisted.
pt was seen in MD office 3/31/99 w/induration 4cm x 4cm, sore to touch, red;dx early cellulitis versus allerg edema;given pediazole & DPH;seen for f/u 4/2/99 & 4/6/99;mom had not informed nurse of reaction until 5/10/99;
Pt developed rash which he showed to pharmacist covering left shoulder 2 weeks after flu shot given.
We were performing influenza desensitization on patient. We had administered 1:100 dilution 0.05ml and 1:10 dilution 0.05ml with no problems. Approx 13 minutes after 3rd dose of full strength 0.05ml IM patient developed hives on chin, chest and 1 large hive on his belly. We administered BENADRYL 12.5mg and monitored pt. No additional problems.
Extreme chills, body aches,  headache, ear pain.  Not accompanied by fever. Began 5.5 hours after injection .  Chills subsided 10 hours after onset.  Headache treated with ibuprofin 10 hours after onset.
given an additional Fluzone vaccine by accident with no reported adverse event; Initial information received on 21-Sep-2023 regarding an unsolicited valid non-serious case received from a Nurse.  This case involves an unknown age and unknown gender patient who was given an additional influenza quadrival A-B MULTIDOSE vaccine preserved [Fluzone] vaccine by accident with no reported adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect influenza quadrival a-b multidose vaccine preserved Suspension for injection lot number not reported via unknown route in unknown administration site (dose, strength and expiration date: not provided) for Immunisation (extra dose administered) (unknown latency).Information on the batch number was requested.  Patient that was given an additional Fluzone vaccine by accident. 2 days prior, the patient already got the 1st Fluzone vaccine dose.  Action taken- not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.